Abstract:

With the update of the pathologic mechanisms of diabetic retinopathy (DR), currently medication therapy has also made some progress, including corticosteroids, anti-vascular endothelial growth factor, anti-platelet derived growth factor, non-steroidal anti-inflammatory drugs, as well as drugs to improve the function of the optic nerve. Currently, in the treatment of diabetic macular edema, intravitreal pharmacotherapies, especially anti-vascular endothelial growth factor (anti-VEGF) agents, have gained popularity.